These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 215463)

  • 1. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between prostacyclin and thromboxane A2.
    Moncada S; Vane JR
    Ciba Found Symp; 1980; 78():165-83. PubMed ID: 6258879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin in physiology and pathophysiology.
    Vane JR; Bunting S; Moncada S
    Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207
    [No Abstract]   [Full Text] [Related]  

  • 5. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
    Gryglewski RJ; Dembínska-Kieć A; Korbut R
    Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic interaction of prostaglandin, thromboxane and prostacyclin: potential clinical applications.
    Bell TG; Smith WL; Oxender WD
    J Environ Pathol Toxicol Oncol; 1986; 6(3-4):191-201. PubMed ID: 3012063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin: its biosynthesis, actions and clinical potential.
    Moncada S; Vane JR
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):305-29. PubMed ID: 6117893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins, platelets, and atherosclerosis.
    Gryglewski RJ
    CRC Crit Rev Biochem; 1980; 7(4):291-338. PubMed ID: 6771102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin I2 (prostacyclin).
    Kelton JG; Blajchman MA
    Can Med Assoc J; 1980 Jan; 122(2):175-9. PubMed ID: 6988063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet and blood vessel arachidonate metabolism and interactions.
    Needleman P; Wyche A; Raz A
    J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
    Moncada S
    Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostanoids in platelet-vascular interactions.
    Martin TJ; Smith IL; Nolan RD; Dusting GJ
    Am J Cardiol; 1983 Jul; 52(2):22A-27A. PubMed ID: 6346850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
    Vane JR
    J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients.
    Weksler BB; Pett SB; Alonso D; Richter RC; Stelzer P; Subramanian V; Tack-Goldman K; Gay WA
    N Engl J Med; 1983 Apr; 308(14):800-5. PubMed ID: 6339916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of arachidonic acid metabolites to atherosclerosis.
    Dembińska-Kieć A; Gryglewski RJ
    Wien Klin Wochenschr; 1986 Apr; 98(7):198-206. PubMed ID: 3010578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.
    Moncada S; Vane JR
    N Engl J Med; 1979 May; 300(20):1142-7. PubMed ID: 219340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.